Nine years' experience of an educational programme for patients treated with oral anticoagulants in a cardiology department.

IF 1.5 4区 医学 Q3 PHARMACOLOGY & PHARMACY
Elisabeth Leclerc, Pauline Cavagna, Anne-Claire Cuquel, Cécile Chung, Victoria Gauthier, Diane Lastennet, Christine Fernandez, Ernesto Brito, Ariel Cohen, Marie Antignac
{"title":"Nine years' experience of an educational programme for patients treated with oral anticoagulants in a cardiology department.","authors":"Elisabeth Leclerc, Pauline Cavagna, Anne-Claire Cuquel, Cécile Chung, Victoria Gauthier, Diane Lastennet, Christine Fernandez, Ernesto Brito, Ariel Cohen, Marie Antignac","doi":"10.1136/ejhpharm-2024-004372","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Oral anticoagulants present significant risks of iatrogenic complications. An educational programme dedicated to patients treated with vitamin-K antagonists (VKAs) or direct oral anticoagulants (DOACs) was set up in our cardiology department in 2013. The aim of this study is to describe and assess our programme's effectiveness, through evaluation of patients' skills and adherence, and to identify associated factors.</p><p><strong>Methods: </strong>Skills were assessed through a questionnaire designed by our multidisciplinary team, targeting different items, and a global score was rated from 0 to 1. Adherence was assessed using a validated tool. Data from patients educated between January 2013 and December 2021 were collected retrospectively. R software was used for statistical analysis, performing Student or χ<sup>2</sup> tests for comparison of variables and univariate linear regression analysis for identification of variability factors. A value of p<0.05 was considered significant.</p><p><strong>Results: </strong>Since 2013, 934 patients were educated, representing 14.7% of patients with oral anticoagulants in cardiology units. Mean±SD age was 68.7±16.4 years and the proportion of men was 58.9%. After hospital discharge, skills were assessed for 334 patients: mean score was 0.80±0.17 (minimum 0.1 to maximum 1). Younger patients presented higher scores than older ones (p<0.001). Adherence was assessed for 331 patients: levels were high, medium and low for 58%, 31.4% and 10.6% of them, respectively. Women presented higher adherence than men (p=0.01). Neither oral anticoagulant type (VKA or DOAC) nor characteristics of educational sessions presented significant association with skills or adherence.</p><p><strong>Conclusions: </strong>Our programme educated a large number of patients and seems to fit with VKAs and DOACs. Improvement areas could be to increase patient assessment and to reinforce education of elderly patients.</p>","PeriodicalId":12050,"journal":{"name":"European journal of hospital pharmacy : science and practice","volume":" ","pages":""},"PeriodicalIF":1.5000,"publicationDate":"2025-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of hospital pharmacy : science and practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/ejhpharm-2024-004372","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Oral anticoagulants present significant risks of iatrogenic complications. An educational programme dedicated to patients treated with vitamin-K antagonists (VKAs) or direct oral anticoagulants (DOACs) was set up in our cardiology department in 2013. The aim of this study is to describe and assess our programme's effectiveness, through evaluation of patients' skills and adherence, and to identify associated factors.

Methods: Skills were assessed through a questionnaire designed by our multidisciplinary team, targeting different items, and a global score was rated from 0 to 1. Adherence was assessed using a validated tool. Data from patients educated between January 2013 and December 2021 were collected retrospectively. R software was used for statistical analysis, performing Student or χ2 tests for comparison of variables and univariate linear regression analysis for identification of variability factors. A value of p<0.05 was considered significant.

Results: Since 2013, 934 patients were educated, representing 14.7% of patients with oral anticoagulants in cardiology units. Mean±SD age was 68.7±16.4 years and the proportion of men was 58.9%. After hospital discharge, skills were assessed for 334 patients: mean score was 0.80±0.17 (minimum 0.1 to maximum 1). Younger patients presented higher scores than older ones (p<0.001). Adherence was assessed for 331 patients: levels were high, medium and low for 58%, 31.4% and 10.6% of them, respectively. Women presented higher adherence than men (p=0.01). Neither oral anticoagulant type (VKA or DOAC) nor characteristics of educational sessions presented significant association with skills or adherence.

Conclusions: Our programme educated a large number of patients and seems to fit with VKAs and DOACs. Improvement areas could be to increase patient assessment and to reinforce education of elderly patients.

在心脏病科为接受口服抗凝治疗的患者提供九年的教育项目经验。
目的:口服抗凝剂存在显著的医源性并发症风险。2013年,我们的心内科设立了一个专门针对接受维生素k拮抗剂(VKAs)或直接口服抗凝剂(DOACs)治疗的患者的教育项目。本研究的目的是通过评估患者的技能和依从性来描述和评估我们项目的有效性,并确定相关因素。方法:通过我们多学科团队设计的问卷,针对不同的项目进行技能评估,整体得分从0到1。使用经过验证的工具评估依从性。回顾性收集2013年1月至2021年12月接受教育的患者的数据。采用R软件进行统计分析,变量比较采用Student检验或χ2检验,变异因素识别采用单因素线性回归分析。结果值:自2013年以来,934例患者接受了教育,占心内科口服抗凝药物患者的14.7%。平均±SD年龄为68.7±16.4岁,男性占58.9%。出院后,对334例患者进行技能评估:平均得分为0.80±0.17(最小0.1至最大1)。结论:我们的方案教育了大量患者,似乎符合vka和doac。改进的领域可以是增加对患者的评估和加强对老年患者的教育。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.40
自引率
5.90%
发文量
104
审稿时长
6-12 weeks
期刊介绍: European Journal of Hospital Pharmacy (EJHP) offers a high quality, peer-reviewed platform for the publication of practical and innovative research which aims to strengthen the profile and professional status of hospital pharmacists. EJHP is committed to being the leading journal on all aspects of hospital pharmacy, thereby advancing the science, practice and profession of hospital pharmacy. The journal aims to become a major source for education and inspiration to improve practice and the standard of patient care in hospitals and related institutions worldwide. EJHP is the only official journal of the European Association of Hospital Pharmacists.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信